GNH USA

Europe — EMA

Metoject Pen

GNH USA supplies Metoject Pen (Methotrexate), an immunosuppressant for rheumatoid arthritis, psoriasis and Crohn's disease. Request a quote for supply.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Metoject Pen, is an antimetabolite presented as a pre‑filled pen for subcutaneous injection use. It belongs to the immunosuppressant therapeutic class and is employed to treat rheumatoid arthritis, psoriasis, Crohn's disease and certain cancers in adult patients.

GNH USA supplies Metoject Pen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, oncology centres and clinics worldwide. The company ensures product quality through stringent quality‑assurance processes and provides regulatory support for import and distribution across multiple regions.

What is Methotrexate used for?

Methotrexate is used in autoimmune and inflammatory disease management as well as certain oncologic conditions. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin lesion severity and plaque formation. - Crohn's disease: diminishes intestinal inflammation and promotes remission. - Certain cancers (e.g., leukemia, lymphoma): interferes with rapid proliferation of malignant cells.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea or vomiting - Fatigue or weakness - Mouth sores (stomatitis) - Mild elevation of liver enzymes

Serious or Rare Side Effects: - Severe liver toxicity (hepatitis, fibrosis) - Pulmonary toxicity (interstitial pneumonitis, fibrosis) - Bone marrow suppression leading to anemia, leukopenia or thrombocytopenia - Acute kidney injury or renal failure

What precautions apply to Methotrexate?

When using Methotrexate, careful monitoring and specific precautions are essential to minimize risks. - Monitor liver function: perform regular liver enzyme tests. - Monitor blood counts: conduct complete blood count before and during therapy. - Assess renal function: evaluate creatinine clearance prior to initiation. - Avoid use in pregnancy: contraindicated; ensure effective contraception for both sexes. - Review concomitant medications: adjust doses of nephrotoxic or hepatotoxic drugs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Methotrexate interact with?

Methotrexate interacts with several medicines that can alter its efficacy or increase toxicity.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of renal toxicity. - Trimethoprim‑sulfamethoxazole: may enhance bone marrow suppression. - Live vaccines: risk of severe infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Azathioprine or other immunosuppressants: additive myelosuppression. - Proton pump inhibitors: may affect absorption. - Oral contraceptives: may reduce effectiveness of methotrexate. - Alcohol: can exacerbate liver toxicity.

Frequently asked questions

What conditions is Metoject Pen used to treat?+
Metoject Pen delivers methotrexate, which is indicated for rheumatoid arthritis, moderate to severe plaque psoriasis, Crohn's disease, and certain malignancies such as leukemia and lymphoma. The drug helps control inflammation and suppresses abnormal cell growth in these disorders.
How does methotrexate work in the body?+
Methotrexate blocks the enzyme dihydrofolate reductase, halting the formation of tetrahydrofolate needed for DNA and RNA synthesis. This limits the proliferation of rapidly dividing cells, including activated immune cells and cancer cells, and also raises extracellular adenosine levels, providing anti‑inflammatory effects.
What determines the dose of Metoject Pen?+
The dose of Metoject Pen is individualized by the prescribing clinician based on the specific indication, disease severity, patient weight, renal and hepatic function, and response to therapy. No standard dosing can be provided without a medical assessment.
Is Metoject Pen safe during pregnancy or breastfeeding?+
Methotrexate is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to a high risk of fetal malformations and miscarriage. It is also excreted in breast milk, so breastfeeding is not recommended while using this medication.
How do I order Metoject Pen from GNH USA?+
To request Metoject Pen, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and any required import documentation.
How does Metoject Pen compare with other methotrexate formulations or alternatives?+
Metoject Pen offers a convenient pre‑filled subcutaneous delivery system, which can improve patient adherence compared with oral tablets that may have variable absorption. Compared with other injectable forms, the pen provides precise dosing and reduces injection‑site discomfort. Alternative disease‑modifying agents, such as biologic DMARDs, have different mechanisms and safety profiles, so choice depends on clinical response and physician judgment.
What are the recommended storage conditions for Metoject Pen?+
Metoject Pen should be stored in a refrigerator at 2‑8 °C (36‑46 °F). Keep the pen in its original packaging, protect it from light, and avoid freezing or shaking. If a short period outside the refrigerator is unavoidable, follow the manufacturer’s guidance on temperature excursions.
How is Metoject Pen administered?+
Metoject Pen is a pre‑filled, single‑use device designed for subcutaneous injection. After confirming the prescribed dose, the pen is placed against the skin (typically on the abdomen or thigh), the needle is activated, and the medication is delivered by pressing the plunger. Patients should be trained by a healthcare professional on proper technique and disposal.
What are the most serious risks associated with Metoject Pen?+
The most serious adverse events include severe liver toxicity, pulmonary fibrosis or interstitial pneumonitis, profound bone‑marrow suppression leading to anemia, leukopenia or thrombocytopenia, and acute kidney injury. Early detection through regular laboratory monitoring is essential to mitigate these risks.
Who should not use Metoject Pen?+
Metoject Pen is contraindicated in pregnant women, individuals planning pregnancy without effective contraception, and patients with severe hepatic or renal impairment. It should also be avoided in patients with known hypersensitivity to methotrexate or any component of the pen, and in those receiving live vaccines due to heightened infection risk.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Subcutaneous Use
Manufacturer
Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU